课题基金 / 基金详情

Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada

Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada
制定将真实世界证据纳入加拿大癌症药物资助决策的框架
批准号：
360956
负责人：
Chan Kelvin K
金额：
$1.42万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-10-01 至 2017-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=360956&lang=en
关键词：
Health Technology Assessment Real World Evidence

项目摘要

项目成果

Chan Kelvin K的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Drug costs represent a rapidly growing expense for public health care systems. In cancer care, the emergence of new treatments has become a regular occurrence and easily outpaces budget growth. As a result, provincial funders must use evidence to prioriti
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
Developing a national Real-World Evidence decision making framework
Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada
A Multi-Province Approach to Real World Evidence Development for Cancer Drugs: A Case Study of Melanoma
海外基金